Please use this identifier to cite or link to this item:
https://hdl.handle.net/11147/8906
Title: | Curcumin: Novel Treatment in Neonatal Hypoxic-Ischemic Brain Injury | Authors: | Rocha-Ferreira, Eridan Sisa, Claudia Bright, Sarah Fautz, Tessa Harris, Michael Riquelme, Ingrid Contreras Kurulday, Tuğçe Hristova, Mariya |
Keywords: | Curcumin Hypoxia Ischemia Neuroprotection Neonate Oxidative stress |
Publisher: | Frontiers Media S.A. | Abstract: | Hypoxic-ischemic encephalopathy (HIE) is a major cause of mortality and morbidity in neonates, with an estimated global incidence of 3/1,000 live births. HIE brain damage is associated with an inflammatory response and oxidative stress, resulting in the activation of cell death pathways. At present, therapeutic hypothermia is the only clinically approved treatment available for HIE. This approach, however, is only partially effective. Therefore, there is an unmet clinical need for the development of novel therapeutic interventions for the treatment of HIE. Curcumin is an antioxidant reactive oxygen species scavenger, with reported anti-tumor and anti-inflammatory activity. Curcumin has been shown to attenuate mitochondrial dysfunction, stabilize the cell membrane, stimulate proliferation, and reduce injury severity in adult models of spinal cord injury, cancer, and cardiovascular disease. The role of curcumin in neonatal HIE has not been widely studied due to its low bioavailability and limited aqueous solubility. The aim of this study was to investigate the effect of curcumin treatment in neonatal HIE, including time of administration and dose-dependent effects. Our results indicate that curcumin administration prior to HIE in neonatal mice elevated cell and tissue loss, as well as glial activation compared to HI alone. However, immediate post-treatment with curcumin was significantly neuroprotective, reducing grey and white matter tissue loss, TUNEL+ cell death, microglia activation, reactive astrogliosis, and iNOS oxidative stress when compared to vehicle-treated littermates. This effect was dose-dependent, with 200 mu g/g body weight as the optimal dose-regimen, and was maintained when curcumin treatment was delayed by 60 or 120 min post-HI. Cell proliferation measurements showed no changes between curcumin and HI alone, suggesting that the protective effects of curcumin on the neonatal brain following HI are most likely due to curcumin's anti-inflammatory and antioxidant properties, as seen in the reduced glial and iNOS activity. In conclusion, this study suggests curcumin as a potent neuroprotective agent with potential for the treatment of HIE. The delayed application of curcumin further increases its clinical relevance. | Description: | PubMed: 31798458 | URI: | https://doi.org/10.3389/fphys.2019.01351 https://hdl.handle.net/11147/8906 |
ISSN: | 1664-042X |
Appears in Collections: | Molecular Biology and Genetics / Moleküler Biyoloji ve Genetik PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
fphys-10-01351.pdf | 16.24 MB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
32
checked on Jan 31, 2025
WEB OF SCIENCETM
Citations
28
checked on Feb 1, 2025
Page view(s)
212
checked on Feb 3, 2025
Download(s)
170
checked on Feb 3, 2025
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.